We believe that Israeli equities have largely discounted the economic impact of this summers’ war with Hamas. Shekel denominated share prices have rebounded and there is ample technical evidence of a bottoming out in the prices of financial stocks...
Our short term outlook for Israeli Global Equities remains neutral with a bullish bias as BIGI® has not broken through key technical resistance levels despite its sharp recovery from October’s lows.
The S&P 500 index gained 1.10% in Q3 2014. MSCI EAFE and MSCI EM lost -5.80% and -3.40%, respectively. Israeli companies continued to list on U.S. exchanges during the quarter. Among the most notable were technology companies Mobileye, CyberArk and ReWalk. They will all be eligible to enter the BIGI and/or the BIGITech during the December 2014 rebalancing.
This is an updated version of our inaugural “BluePaper,” originally published in February 2014, on a topic that is highly relevant to prospective investors in Israeli equities. We contrast the perception of risk in Israeli markets versus the reality of economic resilience and correlations with global rather than local events.